E-LIB Suche - Ergebnisse für: Utsugisawa, Kimiaki

1

Long-term safety and efficacy of zilucoplan in patients wit..:

Howard Jr, James F. ; Bresch, Saskia ; Farmakidis, Constantine...
Therapeutic Advances in Neurological Disorders. 17 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

2

Long-term safety, tolerability, and efficacy of efgartigimo..:

Howard Jr., James F. ; Bril, Vera ; Vu, Tuan...
Frontiers in Neurology. 14 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

3

Improvement of fatigue in generalised myasthenia gravis wit..:

Weiss, Michael D. ; Freimer, Miriam ; Leite, M. Isabel...
Journal of Neurology. 271 (2024) 5 - p. 2758-2767 , 2024

Link: https://doi.org/10.1007/..

4

Therapeutic Responses to Efgartigimod for Generalized Myast..:

Suzuki, Shigeaki ; Uzawa, Akiyuki ; Nagane, Yuriko...
Neurology Clinical Practice. 14 (2024) 3 - p. , 2024

Link: https://doi.org/10.1212/..

5

Taste disorders and alopecia in myasthenia gravis:

Uzawa, Akiyuki ; Suzuki, Shigeaki ; Kuwabara, Satoshi...
BMC Neurology. 24 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

6

Worsening of myasthenic symptoms associated with statins:

Sugimoto, Takamichi ; Suzuki, Shigeaki ; Uzawa, Akiyuki...
Journal of the Neurological Sciences. , 2024

Link: https://doi.org/10.1016/..

7

Real‐world experience with eculizumab and switching to ravu..:

Tokuyasu, Daiki ; Suzuki, Shigeaki ; Uzawa, Akiyuki...
Annals of Clinical and Translational Neurology. 11 (2024) 5 - p. 1338-1346 , 2024

Link: https://doi.org/10.1002/..

8

Long-Term Safety, Tolerability, And Efficacy of Efgartigimo..:

Pasnoor, Mamatha ; Bril, Vera ; Karam, Chafic...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

9

Achievement of Improved Post-Intervention Status in Patient..:

Muppidi, Srikanth ; Narayanaswami, Pushpa ; Meisel, Andreas...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

10

Efficacy of Rozanolixizumab in Generalized Myasthenia Gravi..:

Vu, Tuan ; Drużdż, Artur ; Grosskreutz, Julian...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

11

Long-term safety, tolerability, and efficacy of efgartigimo..:

Bril, Vera ; Pasnoor, Mamatha ; Karam, Chafic...
Journal of the Neurological Sciences. 455 (2023) - p. 121089 , 2023

Link: https://doi.org/10.1016/..

12

Rozanolixizumab responder and minimal symptom expression ra..:

Bril, Vera ; Vissing, John ; Drużdż, Artur...
Journal of the Neurological Sciences. 455 (2023) - p. 122016 , 2023

Link: https://doi.org/10.1016/..

13

Clinical features and outcomes of patients with muscle-spec..:

Yasuda, Manato ; Uzawa, Akiyuki ; Kuwabara, Satoshi...
Journal of Neuroimmunology. 385 (2023) - p. 578241 , 2023

Link: https://doi.org/10.1016/..

14

Score fluctuation might be associated with a higher placebo..:

Howard Jr, James F ; Boroojerdi, Babak ; de la Borderie, Guillemette..
The Lancet Neurology. 22 (2023) 11 - p. 982-983 , 2023

Link: https://doi.org/10.1016/..

15

Dose Selection and Clinical Development of Efgartigimod PH2..:

Li, George ; Li, Yuebing ; Vu, Tuan...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..